tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi
The FlyH.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi
7d ago
NVS
CHRO
mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
PremiumThe Fly
mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
11d ago
MRK
BNTX
Roche announces new two-year data from Phase IIIb/IV SALWEEN study
PremiumThe Fly
Roche announces new two-year data from Phase IIIb/IV SALWEEN study
11d ago
CHRO
Roche receives FDA approval for companion diagnostic tests for Ziihera
PremiumThe Fly
Roche receives FDA approval for companion diagnostic tests for Ziihera
13d ago
CHRO
JAZZ
Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test
PremiumThe Fly
Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test
15d ago
DGX
CHRO
Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease
PremiumThe FlyLabcorp to offer Elecsys pTau-217 test for Alzheimer’s disease
15d ago
LH
Roche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA
Premium
The Fly
Roche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA
19d ago
CHRO
Ideaya Biosciences enters IDE892 collaboration with Genentech
Premium
The Fly
Ideaya Biosciences enters IDE892 collaboration with Genentech
20d ago
CHRO
IDYA
Roche upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Roche upgraded to Overweight from Equal Weight at Morgan Stanley
1M ago
CHRO
Roche expands cyclospora testing portfolio to support US public health response
PremiumThe Fly
Roche expands cyclospora testing portfolio to support US public health response
1M ago
CHRO
Labcorp launches FDA-approved PTEN companion diagnostic for prostate cancer
PremiumThe Fly
Labcorp launches FDA-approved PTEN companion diagnostic for prostate cancer
1M ago
LH
Genprex announces collaboration with Roche Diagnostics
PremiumThe Fly
Genprex announces collaboration with Roche Diagnostics
1M ago
CHRO
GNPX
Roche announces EMA’s CHMP recommended approval of Susvimo
PremiumThe FlyRoche announces EMA’s CHMP recommended approval of Susvimo
2M ago
CHRO
Roche receives FDA 510(k) clearance for cobas BV/CV assay
Premium
The Fly
Roche receives FDA 510(k) clearance for cobas BV/CV assay
2M ago
CHRO
Roche confirms FY26 outlook
Premium
The Fly
Roche confirms FY26 outlook
2M ago
CHRO
Roche reports 1H group sales CHF 30.4B vs. CHF 30.9B last year
PremiumThe Fly
Roche reports 1H group sales CHF 30.4B vs. CHF 30.9B last year
2M ago
CHRO
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
PremiumThe Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
2M ago
XE
AAL
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
PremiumThe Fly
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
2M ago
AZN
BMY
MaxCyte enters technology license partnership with Genentech
PremiumThe Fly
MaxCyte enters technology license partnership with Genentech
2M ago
CHRO
MXCT
Roche names Dan Malarek as President and CEO of Roche Diagnostics North America
PremiumThe FlyRoche names Dan Malarek as President and CEO of Roche Diagnostics North America
2M ago
CHRO
Genentech granted priority review for Gazyva sBLA by FDA
Premium
The Fly
Genentech granted priority review for Gazyva sBLA by FDA
2M ago
CHRO
Nurix Therapeutics price target raised to $34 from $32 at Truist
Premium
The Fly
Nurix Therapeutics price target raised to $34 from $32 at Truist
2M ago
CHRO
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >